About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Adherence to Aromatase Inhibitors: The Role of Partners

Adherence to Aromatase Inhibitors: The Role of Partners

NCT02753985·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Abramson Cancer Center at Penn Medicine

Age

18–any

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

Women and partners of women with stage I-III breast cancer who
1. have completed primary cancer treatments (surgery, chemotherapy, radiotherapy)
2. have experienced AI side effects
3. live with a romantic partner.

The record

StatusCompleted

PhaseNo phase

Taking part40

StartedJul 2014

UpdatedJul 23, 2019

Conditions

Breast Cancer Survivors

Where1

Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States